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Annonaceous acetogenins (AAGs) are environmental neurotoxins
from the fruit pulp of several Annonaceae species, whose con-
sumption was linked to the occurrence of sporadic atypical Par-
kinsonism with dementia. The quantiﬁcation of the prototypical
AAG annonacin in Rat brain homogenates was performed by UPLC-
MS/MS in selected reaction monitoring (SRM) mode, using a triple
quadrupole mass analyzer. A natural analog of annonacin was used
as an internal standard. Analyzed data set of the analytical valida-
tion of this method is presented, including stability of the samples,
extraction recovery and matrix effect, supporting the results
described in the article “Quantiﬁcation of the environmental neu-
rotoxin annonacin in Rat brain by UPLC-MS/MS” N. Bonneau, I.
Schmitz-Afonso, D. Touboul, A. Brunelle, P. Champy (2016) [1].
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acquiredUPLC-MS/MS: Dionex Ultimate 3000 RSLC system, Triple quadrupole TSQ Van-
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factorsAnalysis of Rat brain homogenates, spiked with annonacinxperimental
featuresSelectivity, carry-over, limits of detection and quantiﬁcation, accuracy, precision,
matrix effect, absolute and relative extraction recovery, stabilityata source
locationBioCIS, Univ. Paris-Sud, Franceata accessibility Data is with this articleDValue of the data Analyzed dataset for the validation assays of the extraction and quantiﬁcation of annonacin in the
Rat brain is presented.
 Data comprise the analytical parameters determined, including stability, recovery and matrix
effect, using UPLC-ESI-triple quadrupole analysis in SRM mode.
 Data are in accordance with the bioanalytical validation criteria set by EMA and can be useful for
methodological development.
 They constitute benchmarks for pharmacokinetic studies of sub-type 1b Annonaceous acetogenins.1. Data
The dataset includes the choice of an internal standard and the method validation for the quan-
tiﬁcation of annonacin, a neurotoxic polyketide, in Rat brain homogenates, by UPLC-ESI(þ)-Triple
quadrupole. Analyzed data for selectivity, carry-over, limits of detection and quantiﬁcation, accuracy,
precision, matrix effect, absolute extraction recovery, relative extraction recovery and stability are
presented.2. Experimental design, materials and methods
2.1. Selection of IS
Annonacin and other AAGs, including isotope-labeled compounds, are not commercially available.
Annonacinone (IS) was therefore selected as an Internal Standard (IS), because of its structural
similarity with annonacin, resulting in a similar fragmentation pattern [2] with the same speciﬁc loss
of γ-methyl-γ-lactone (112 amu). Indeed the structure of IS is identical to that of annonacin except
for a ketone instead of a hydroxyl-group at C-10 (Fig. 1). The UPLC-MS/MS analysis conditions were
identical to those previously developed for the determination of annonacin in Rat plasma [3]. A full
scan MS of annonacin and IS shows that [MþNa]þ ions (m/z 619.4 and m/z 617.4, respectively) were
more abundant than [MþH]þ ions (m/z 597.4 and m/z 595.4, respectively). Moreover, only non-
speciﬁc water losses were observed when fragmenting [MþH]þ ions of annonacin and IS, whereas
Fig. 1. The Annonaceous acetogenins annonacin and annonacinone (internal standard). Product ion spectra are presented in [1].
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of the lactonic ring (Fig. 1). Hence, the SRMmode was used to monitor the transitionsm/z 619.4→m/z
507.4 and m/z 617.4 → m/z 505.4, for annonacin and IS, respectively. The [Mþ2] isotope of IS is also
detected when monitoring the transition m/z 619.4 → m/z 507.4 (Fig. 1B in [1]).
2.2. UPLC-MS/MS conditions
Analyses were performed with a Dionex Ultimate 3000 RSLC system equipped with Acquity UPLC
BEH C18 column (2.1100 mm, 1.7 mm, Waters, Guyancourt, France) and pre-column (2.15 mm,
1.7 mm), under previously described chromatographic conditions [1]. A Triple quadrupole TSQ Van-
tage EMR (Thermo Scientiﬁc, Les Ulis, France) equipped with a heated ESI source was used, in the
positive ion mode. The source parameters were set as follows: spray voltage 2000 V, vaporizer
temperature 350 °C, sheath gas (N2) pressure 45 psi (3.1 bars), auxiliary gas pressure (N2) 20 psi
(1.4 bar), capillary temperature 300 °C. The collision energies were set at 36 eV and 37 eV for
annonacin and for the IS, respectively. The data acquisition and processing were performed using
Thermo Scientiﬁc Xcalibur 2.1 software.
2.3. Preparation of calibration standards and quality control samples
Stock solutions of annonacin and IS were prepared at the concentration of 1 mg/mL in methanol
and stored at 20 °C. Working standard solutions of annonacin ranging from 5 to 500 ng/mL were
prepared daily by successive dilutions of a stock solution in methanol. The stock solution of IS was
diluted daily to prepare a working solution at the concentration 100 ng/mL.
The calibration standards were prepared by spiking 1 mL of pooled Rat brain homogenate
obtained by sonication in methanol (0.2 g/mL) with 10 μL of IS working solution to reach the con-
centration of 5 ng/g and with 10 μL of annonacin in solution of appropriate concentration, to reach
0.25; 0.375; 0.5; 1; 2.5; 3.75; 5; 10; 12.5; and 25 ng/g concentrations, respectively. In order to evaluate
intra- and inter-day precisions and accuracy, Quality Control (QC) samples were prepared in brain
homogenate at the concentrations of 0.25; 0.5; 5; 25 ng/g.
2.4. Method validation
The dataset of method validation assay described here comprises selectivity, carry-over, linearity,
accuracy, precision, matrix effect, extraction recovery, and stability, according to the EMA guideline on
bioanalytical method validation [4].
2.4.1. Selectivity
Data for selectivity determination were obtained on individual brain homogenates. The method
was considered selective (absence of interfering component in the matrix) as the response areas at
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quantiﬁcation (LLOQ) for annonacin, and less than 5% for IS [4], in all runs. For the different blank
matrices tested, no interfering compound was detected at the expected retention times of annonacin
and IS.
2.4.2. Carry-over
Data for carry-over evaluation were obtained in blank analytical runs following the injection of the
upper limit of quantiﬁcation (ULOQ). The response areas at the retention times of annonacin and of IS
were respectively less than 20% of the LLOQ for annonacin and less than 5% for IS, as recommended
[4]. No carry-over was observed during the analysis, as assessed after injection of annonacin at ULOQ,
neither for IS at working concentration.
2.4.3. Calibration curve and lower limit of quantiﬁcation (LLOQ)
A calibration curve was designed to cover the expected range of concentration for brain samples
[1]. Calibration curves were prepared for each run of analysis, plotting the peak area ratio y of
annonacin to IS as a function of the nominal concentration of each calibration level x and then ﬁtted
by linear regression. The LLOQ was deﬁned as the lowest concentration in the calibration curve with a
back calculation accuracy expressed as relative error within 720% and a precision within 720% [4].
The calibration curves were accepted as back calculated concentrations of the calibration standards
were within 715%.
2.4.4. Accuracy and precision
Data for the evaluation of accuracy and precision were obtained at 4 concentration levels,
including LLOQ (0.25 ng/g), low (LQC; 0.5 ng/g), medium (MQC; 5 ng/g) and ULOQ (25 ng/g), with
3 replicates a day, and at two different days. Quality control (QC) samples at 4 different concentra-
tions, including LLOQ and ULOQ, were prepared at 2 different days, with 3 replicates a day, inde-
pendently of the calibration standards. Within- and between-run precisions were less than 7 15%.
Moreover, within- and between-run accuracies were less than 715% of the nominal concentration
(Table 1).
2.4.5. Matrix effect
The matrix effect was investigated by comparison of the peak areas of post-extraction spiked
samples at LLOQ and ULOQ, in 3 individual homogenates samples versus standard solutions of the
same levels. This was performed in triplicate on each homogenate. IS-normalized matrix factor (IS-
MF) was calculated. The matrix effect was considered acceptable as the RSD of IS-MF obtained from
the 3 individual Rat brains was less than 15%.
A high absolute matrix effect was observed, with signal enhancement for both annonacin and IS.
High relative matrix effect was observed at the LLOQ and ULOQ (Table 2). Despite these differences,
IS-relative matrix factor evaluated on 3 different brain samples was within 15% at each concentration,
as recommended [4].Table 1
Precision and accuracy for the determination of annonacin in Rat brain (n¼3).
Concentration
(ng/g)
Within-run Between-run
Pecision Accuracy % Precision Accuracy %
(RSD %) Mean 7SD (RSD %) Mean 7SD
0.25 10.0 113.9 8.0 9.0 114.3 10.3
0.50 5.8 105.8 7.9 5.6 102.6 5.8
5 8.3 93.1 1.1 3.3 100.6 9.0
25 3.4 90.1 4.5 14.0 100.2 11.4
Table 2
Evaluation of matrix effect on 3 individual Rat brain homogenates (mean7RSD%).
n¼3 individual brain
homogenates
Concentration
(ng/g)
Matrix factor % IS-normalized matrix factor
%
Mean 7RSD Mean 7RSD
Annonacin 0.25 502 6 294 6
25 279 13 148 4
IS 5 171 4
Table 3
Extraction recovery of annonacin and IS (n¼3, mean 7 Δmax %).
n¼3 Concentration
(ng/g)
Absolute recovery % Relative recovery %
Mean 7 Δmax Mean 7 Δmax
Annonacin 0.25 5.0 1.2 56.2 7.8
25 10.7 1.5 66.1 4.2
Annonacinone (IS) 5 7.2 2.6
Table 4
Stability of annonacin in Rat brain homogenates (n¼3).
n¼3 Concentration (ng/g) % of nominal concentration
Mean 7SD
4 h RT 0.25 110 7
25 93 3
3 cycles 20 °C - RT 0.25 108 5
25 92 5
24 h autosampler 4 °C 0.25 102 2
25 91 1
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The extraction recovery was evaluated by comparison of the peak areas of extracted samples
versus post-extraction spiked samples at LLOQ and ULOQ, in triplicate (Table 3). Recovery for anno-
nacin relative to IS, as well as absolute recoveries for annonacin and IS are presented. Absolute
recovery was very low (5–10%). However, the relative recovery was reproducible, with a maximal
error of 15%, calculated as: Δ(BE/PE)¼ 100*(meanPE*SDBEþmeanBE*SDPE)/(meanPE)2; where BE is the
area before extraction and PE the area after extraction.
2.4.7. Stability
The stability of annonacin during sample processing and storage was evaluated in triplicate at room
temperature during 4 h, under three freeze-thaw cycles, and during 24 h on the autosampler at 4 °C.
Analysis performed in triplicate at three concentration levels, LLOQ, MQC and ULOQ, showed variations
within 715% of their nominal concentration, evidencing no loss of annonacin during the process (Table 4).Acknowledgments
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